Moderna stock heads into the open after a 1.8 percent drop

At the close on September 8, 2026, Moderna stock finished at USD 142.95 on the Nasdaq, down 1.8 percent with options activity skewed toward calls. The shares traded within a narrow intraday range and moved in line with a weaker broader market.

Moderna stock closed at USD 142.95 on the Nasdaq on September 8, 2026, losing 1.8% from the prior session in a relatively tight trading range. On the same day, the shares tracked a softer broader US market, with major indexes slipping as investors reacted to rising oil prices and geopolitical tensions.

September 8, 2026 in numbers

Moderna Inc. (ISIN US60770K1034, Nasdaq: MRNA) ended the September 8, 2026 session at USD 142.95 on the Nasdaq, down USD 2.60 or 1.8% from a previous close near USD 145.55, according to market data. Intraday, the stock traded near an indicated low around USD 140 and a high closer to USD 146, leaving the close in the middle portion of the day’s range. Options activity on the same day showed moderately bullish positioning, with roughly 44,000 contracts traded and calls outnumbering puts, as highlighted by TipRanks. Against this backdrop, the S&P 500 declined between 0.4% and 0.6% on September 8, 2026, reflecting pressure from higher oil prices and renewed geopolitical concerns, as reported by Zacks and WTOP. This left Moderna’s decline roughly in line with the overall equity pullback.

Today’s factors for Moderna

Today, September 9, 2026, Moderna’s share performance ahead of the open is shaped mainly by the previous session’s move and the broader macro backdrop rather than a fresh company-specific release in the early morning. The recent surge in the stock over the past month has drawn increased attention from analysts and investors, with a focus on how options positioning and market volatility could influence trading patterns, as discussed in a broader context by Zacks. In addition, overall US equity sentiment today is likely to be affected by ongoing developments in energy markets and geopolitical news, which weighed on major indexes on September 8, 2026, according to Pittsburgh Post-Gazette. Any new sector news or macro data releases during the day could further steer sentiment toward biotechnology names such as Moderna.